Penn Mutual Asset Management, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 40 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Penn Mutual Asset Management, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$677,018
+2.1%
675,0000.0%0.64%
-13.2%
Q4 2022$663,188
+0.9%
675,0000.0%0.74%
-14.0%
Q3 2022$657,000
+0.2%
675,0000.0%0.86%
-2.7%
Q2 2022$656,000
-1.2%
675,0000.0%0.88%
+14.8%
Q1 2022$664,000
-0.2%
675,000
+99900.0%
0.77%
+8.0%
Q4 2021$665,000
-1.0%
6750.0%0.71%
-32.9%
Q3 2021$672,000
+0.9%
6750.0%1.06%
+27.8%
Q2 2021$666,000
+2.3%
675
-99.9%
0.83%
+13.2%
Q1 2021$651,000
+1.7%
675,0000.0%0.74%
+30.1%
Q4 2020$640,000
+29.8%
675,000
+25.0%
0.56%
-18.8%
Q3 2020$493,000540,0000.70%
Other shareholders

There were no reported owners of SUPERNUS PHARMACEUTICALS INC in Q3 2022.

NameSharesValueWeighting ↓
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders